FDA Investigator Hugh Grimoldby

Hugh Grimoldby has inspections in 2 countries as of 19 Oct 2023. Hugh Grimoldby has collaborated with a combinined 4948 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
495
Last Inspection Date:
19 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Sweden
Co-Investigator(s):
Aaron J Poloni, Abby M Miller, Abigail A Andersen, Adamsr, Ademola O Daramola, Alan D Grupe, Alexander M Kay, Alexandra B Pitkin, Alicia M Weitzel, Alvin E Easter, Alvin Easter, Amber M Howell, Amy R Glynn, Andrew K Haack, PhD, Andrew S Johnson, Anh Trinh T Nguyen, Anita Narula, PhD, Arie R Dyk, Arsen Karapetyan, Ashleigh P Barkans, Ava M Bowman, Avery J Dennis, Barbara J Rincon, Beau R Lamb, Belinda E Clifton, Binh T Nguyen, Bowman, Bradley E Tufto, Brenda K Alford, Brenda L Reihing, Brian E Thompson, Brian P Hendrickson, Brian Ravitch, Bruce R Burrell, Bryan L Mcguckin, Bryce E Mansfield, Cajsha White, Camille Bennett Hoffman, Carl A Anderson, Carr Sharpe, Catherine J Laufmann, Ce'nedra M Martin, Celena Ngo, Celia L Hutchinstein, Celia L Silverstein, Christina L Norton, Christopher E Rezendes, Christopher R Czajka, Clinton R Vanblaricom, Colleen M Jones, Crystal A Harlan, Cullen T Wilson, Cynthia L Gorveatt, Dan C Fisher, Daniel A Congdon, David A Quale, David G Whitman, David H Engelskirchen, David J Gomes, David L Hunsaker, Davis, Dawn E Barkans, Deborah A Greco, Deborah A Nebenzahl, Dennis R Hudson, Desiree C Iya, Devon M Shoop, Dewey W Darold, Deyaa Shaheen, Dianne B Latona, Dirk L Lincoln, Dolores E Price, Don A Brunssen, Donald B Mckechnie, Donald W Jehn, Douglas J Scott, Durell L Giles, Dyana K Stone, Edward D Harris, Edwin L Wilkinson, Eileen T Dupont, Elizabeth A Sheller, Elizabeth S Howell, Ellen N Stewart, Emal Wahab, Eric C Andes, Eric C Keane, Eric L Scott, Erika V Butler, Feliser V Hilario, Francisco, Gavin W Pierce, Gerard Pde Leon, Gloria J Baca, MS, Gordon T Wales, Graham N Giesen, Greg K Keshishyan, Hanna L Potter, Harmon M Blanch, Heidi S Marks, Heika R Tait, Henry E Carrillo, Hoover, Hugh A Grimoldby, Hyeongho Ha, Ian J Thomson, Ismael Olvera, IV, Jack L Christy, Jacob N Hamilton, James C Cartwright, James C Henry, James D Hildreth, James E Trabert, James I Vik, James S Cartwright, Jane M Kreis, Janice Chellis, Jason T Lovelady, Jason W Cornell, Jean Brewer, Jean C Colon Lopez, Jean R Mccurry, Jeanne M Weishaar, Jeannine K Wooten, Jeff A Gard, Jeff M Uriarte, Jeffrey J Leclair, Jeffrey N Gerdes, Jennifer Wcheng Dobson, Jessica B Clark, Jessica B Zachman, Jessica L Andrade, Jessica L Kocian, Jessie J Deloach, Jim D Pressley, Jinkee Mvila Binayug, John A Hall, John E Emmert, John W Banks, Jonathan T Little, Joseph A Seitz, Joseph M Hudak, Judy C Nepsa, Julia E Chervoni, Julian C Hanson, Julie A Stocklin, Ka L Wong, Kaitlyn R Kornberg, Karen L Bauer, Karla J Youngberg, Kartherine L Ernest, Kate L Allen, Katharine Chan, Katherine L Arnold, Katherine L Ernest, Kathryn A Krentz, Kawshalya Pathiraja, Kay, Keegan B Mixon, Keishla M Arroyo Lopez, Kelsey A Hustedt, Kelsey A Volkman, Kelsey M Bishop, Kenneth A Glatt, Kenneth O Gee, PhD, Kerry Ann Latham, Kevin T Gerrity, Kham Phommachanh, Kimberly J Proctor Jones, Kimberly M Lichter, Kristina M Phelps, Kurt M Hafer, Lakecha N Lewis, Lance W Bohm, Lanita F Kelley, Laura E Hausch, Lauren E Swantko, Lawrence Y Lee, PhD, Leon R Marquart, Lesley A Swanson, Lester O Boian, Leya A Grosch, Lisa A Bowden, Lisa K Capron, Lon A Cummings, Lori J Silverstein, Lorna F Jones, Lucy Severs, Mai Hang, Malinda C Shelman, Marcus A Goshen, Margo C Jones, Margo Cl Jones, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mark E Imsland, Mark E Moen, Mark L Collins, Mark S Crippen, Mark W Babbitt, Marsha L Mccauley, Matthew D Feist, Matthew R Barr, Michael F Schuette, Michael Govro, Michael H Antee, Michael J Donovan, Michael J Lackey, Michael S Hudson, Michael S Valenzuela, Michelle S Swanson, Mikel T Wright, Nancy E Byerly, Nancy E Doyle, Narahi J Alvarez Alcazar, Neil J Traaen, Ngoc Lant Nguyen, Orval D Mcintire, Othello G Capangpangan, Patrick R Brown, Paul F Rader, Paul M Kawamoto, Paul Rader, Paula J Wilkerson, Peter T Regan, Philip E Ake, Philippe A Cornet, Phillip J Dugger, Phillip J Sample, Rachel J Cantrell, Rachelle M Deskins, Rebecca A Sletner, Rebecca T Davis, Richard A Martin, Richard G Runyon, Richard W Tubb, Rita E Luttrell, Robert A Williams, Robert F Hennes, Robert J Vezzetti, Rocco C Black, Roger F Zabinski, Romero, Ronald E Gill, Ronald L Lahti, S Lori Brown, PhD MPH, Sandra K Wangen, Sangeeta M Khurana, PhD, Sarah M Parkinson, Savini, Scott A Nabe, Scott W Fox, Shahriar Rahmani, Shannon J Hall, Sharon I Gundersen, Sharon K Ferguson, Shelagh D Schopen, Sherri N Rohlf, MD, Sherryl Stoltenow, Sonia R Peterson, Stacy A Schneider, State Agency, Stephanie A Slater, MS, Stephanie J Shaw, Sundy Ven, Sunitha K Rajaram, PhD, Tammy Vasquez Hancock, Tara A Marshall, Tara M Pianko, Tawny L Colling, Thomas C Mclean, CFS, Timothy D Evans, Timothy S Williamson, Tracy K Li, Trudy R Papson, Vanessa Y Gelsey, PhD, Vitaliy N Guyvan, Wayne D Stowell, Wayne L Jefferson, Wilfred J Omoloh, Williamsra, Willis L Hicks, Xiaojun Yan, Yvette Mlacour Davis, Yvonne M Larsen, Zachary A Bogorad, Zachary P Wachlarowicz, Zhongren Wu

Hugh Grimoldby's Documents

Publish Date Document Type Title
September, 2000 EIR Allwater, Inc. - EIR, 2000-09-26
September, 2009 FDA 483 Kirkman Laboratories, Inc. - Form 483, 2009-09-18

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more